STRATEGIC INVESTMENT.

BREAKTHROUGH INNOVATION.

Home 2021-05-03T16:22:16+00:00

Rex Health Ventures (RHV) enables groundbreaking work by investing in and fostering companies and technologies that advance the future of health.

  • Entrepreneur-friendly strategic investor that speeds access to new healthcare products and services to improve patient care
  • Established by UNC REX Healthcare in 2012 as part of its commitment to innovation
  • Partners with emerging companies throughout North Carolina and the U.S.
  • Leverages the talent and subject matter experts across the UNC REX and UNC Health Care network

Learn More

Our Portfolio

Phynd

Learn More

Arrivo BioVentures

Learn More

TARGET PharmaSolutions

Learn More

Veran Medical Technologies

Learn More

Phononic

Learn More

Midnight Pharma LLC

Learn More

Kit Check

Learn More

Baebies

Learn More

Portfolio Spotlight

Phononic is revolutionizing cooling and heating with solid-state thermal management solutions. Named to CNBC’s 2016 Disruptor 50 list for its innovation within the cooling and heating industry, as well as CNBC’s Disruptor 50 list for both 2016 and 2017, Phononic provides solid-state semiconductor technology that can be applied to everything from refrigeration to fiber optics, removing the barriers of traditional approaches and ushering in a new era of cooling and heating.

UNC REX served as the first testing site for Phononic’s medical grade refrigerator, which will now be installed throughout the new NC Heart and Vascular hospital. Learn more in this video.

Learn More

Our Team

Anita Watkins

Director of Strategic Innovations, Rex Health Ventures

Bobby Helmedag

Managing Director, Rex Health Ventures

Natasha Bonett DeLong

Portfolio Manager, Rex Health Ventures

Davis Morton

Investment Analyst, Rex Health Ventures

View All

News

BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device & Surpasses 1,000 Patients Treated Worldwide with the HAART Devices

April 21st, 2021|

BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device & Surpasses 1,000 Patients Treated Worldwide with the HAART Devices View original article on businesswire.com AUSTIN, Texas--(BUSINESS WIRE)--BioStable Science & [...]

Baebies Announces FDA Acknowledgement of Emergency Use Notification for FINDER 1.5 Instrument and FINDER SARS-CoV-2 Test – RT-PCR within 17 Minutes

April 6th, 2021|

Baebies Announces FDA Acknowledgement of Emergency Use Notification for FINDER 1.5 Instrument and FINDER SARS-CoV-2 Test – RT-PCR within 17 Minutes View the original article on BusinessWire.com DURHAM, N.C.--(BUSINESS WIRE)--Baebies, a growth-stage company developing innovative [...]

View All

Contact Us

Contact us to discover what opportunities may be available for your company with Rex Health Ventures.

Get Started